soul trial oral semaglutide cardiovascular outcomes results 2024 2025 nejm Editorial Fellow Harleen Marwah, MD, summarizes the trial. Read the full at NEJM.org (link in bio). , , #ACC25 #Cardiology #ClinicalTrials #NEJM SOUL (Semaglutide cardiOvascular oUtcomes triaL)
Description
FIGHT and LIVE Trials: Liraglutide showed neutral effects in heart failure with reduced ejection fraction (HFrEF), highlighting the need for further research in this phenotype [59,60]
The genetic test does not predict exact medication response
Were not trying to push everyone toward one option or the other
Can pregnant women take Ozempic
